Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H10NO4S.Na |
Molecular Weight | 275.256 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCOC1=CC=C(C2=C1N=CC=C2)S([O-])(=O)=O
InChI
InChIKey=KGBPIIYKHSGTAJ-UHFFFAOYSA-M
InChI=1S/C11H11NO4S.Na/c1-2-16-9-5-6-10(17(13,14)15)8-4-3-7-12-11(8)9;/h3-7H,2H2,1H3,(H,13,14,15);/q;+1/p-1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C11H10NO4S |
Molecular Weight | 252.266 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20860695Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/22480421 | https://www.ncbi.nlm.nih.gov/pubmed/23075132
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20860695
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/22480421 | https://www.ncbi.nlm.nih.gov/pubmed/23075132
Actinoquinol is sunscreen agent that absorbs Ultraviolet B light. Actinoquinol in combination with hyaluronic acid drops might be helpful for the human eye in the defense against photooxidative and other oxidative processes.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0010224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20860695 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22480421
The sterile buffered solution of 0.2 % actinoquinol with 0.15 % hyaluronic acid, pH 7.2 was dropped on the right eye (one drop every 30 s, five drops in total)
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23075132
The inhibition of EBV-EA activation was assayed using the EBV genome carrying lymphoblastoid Raji cells of human origin, which were cultivated in RPMI 1640 medium. The cells were incubated at 370 C for 48 h in 1 mL of the medium containing butyric acid (4 mM, as co-inducer), TPA (20 ng/mL, 32 pM) and a known amount of Actinoquinol in DMSO. Smears were made from cell suspension. The EBV-EA-expressing cells were stained with high titre EBV-EA-positive serum from nasopharyngeal carcinoma patients and detected by an indirect immunofluorescence technique. In each assay, 500 cells were counted, and the experiments were carried out in triplicate. The average EA induction was compared to that of a positive control experiment with butyric acid (4 mM) and TPA (32 pM).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:57:39 GMT 2023
by
admin
on
Fri Dec 15 14:57:39 GMT 2023
|
Record UNII |
8PW272ITDS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C52588
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1356732
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
230-651-8
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
C81721
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
SUB15269MIG
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
DTXSID00993261
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
100000078081
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
8PW272ITDS
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
7246-07-3
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
23675748
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | |||
|
m5
Created by
admin on Fri Dec 15 14:57:39 GMT 2023 , Edited by admin on Fri Dec 15 14:57:39 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |